PT956045E - Vacina de herpesvirus deficiente na morfogenese - Google Patents
Vacina de herpesvirus deficiente na morfogeneseInfo
- Publication number
- PT956045E PT956045E PT97937214T PT97937214T PT956045E PT 956045 E PT956045 E PT 956045E PT 97937214 T PT97937214 T PT 97937214T PT 97937214 T PT97937214 T PT 97937214T PT 956045 E PT956045 E PT 956045E
- Authority
- PT
- Portugal
- Prior art keywords
- deficient
- herpesvirus
- morphogenesis
- assembly
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/687,820 US5972666A (en) | 1996-07-26 | 1996-07-26 | Assembly-deficient herpesvirus vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
PT956045E true PT956045E (pt) | 2005-01-31 |
Family
ID=24761993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97937214T PT956045E (pt) | 1996-07-26 | 1997-07-25 | Vacina de herpesvirus deficiente na morfogenese |
Country Status (14)
Country | Link |
---|---|
US (1) | US5972666A (pt) |
EP (1) | EP0956045B1 (pt) |
JP (1) | JP2000516597A (pt) |
CN (1) | CN1230893A (pt) |
AT (1) | ATE277634T1 (pt) |
AU (1) | AU3977997A (pt) |
BR (1) | BR9710604A (pt) |
CA (1) | CA2261071A1 (pt) |
CZ (1) | CZ17999A3 (pt) |
DE (1) | DE69730993T2 (pt) |
DK (1) | DK0956045T3 (pt) |
ES (1) | ES2231884T3 (pt) |
PT (1) | PT956045E (pt) |
WO (1) | WO1998004286A2 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE50012015D1 (de) * | 1999-02-04 | 2006-03-30 | Joern Bullerdiek | Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs |
US6291226B1 (en) * | 1999-02-25 | 2001-09-18 | National Research Council Of Canada | Adenovirus mutants with deleted protease gene |
HUP0202738A3 (en) * | 1999-09-10 | 2003-12-29 | Akzo Nobel Nv | Equine herpes virus temperature sensitive mutant and live vaccine thereof |
WO2001078776A1 (en) * | 2000-04-13 | 2001-10-25 | Avant Immunotherapeutics, Inc. | Herpes virus complementing cell line |
AU2002305914A1 (en) * | 2001-01-12 | 2002-10-21 | Chiron Corporation | Nucleic acid mucosal immunization |
US7968298B2 (en) * | 2001-03-28 | 2011-06-28 | The United States Of America As Represented By The Department Of Health And Human Services | Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication |
WO2005021746A1 (ja) * | 2003-08-29 | 2005-03-10 | Virus Ikagaku Kenkyusho Inc. | Hhv−6またはhhv−7由来の組換ウイルスベクター、その製造方法、それを用いた宿主細胞の形質転換方法、それにより形質転換された宿主細胞およびそれを用いた遺伝子治療方法 |
US20080089910A1 (en) * | 2004-06-29 | 2008-04-17 | Visalli Et Al | Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof |
US7628993B2 (en) | 2006-07-20 | 2009-12-08 | Vical Incorporated | Compositions and methods for vaccinating against HSV-2 |
CN111117974B (zh) * | 2019-12-20 | 2022-02-22 | 华南农业大学 | 一种可视化绿色荧光猪伪狂犬病毒及其构建方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9102126D0 (en) * | 1991-01-31 | 1991-03-13 | Smithkline Beecham Biolog | Novel vaccine |
JPH05236967A (ja) * | 1991-05-07 | 1993-09-17 | Medical Res Council | ヘルペスウイルス粒子及びワクチン |
WO1996012007A1 (en) * | 1994-10-17 | 1996-04-25 | Merck & Co., Inc. | Stable recombinant hcmv protease |
US5728557A (en) * | 1995-06-01 | 1998-03-17 | Merck & Co., Inc. | Method of making herpes simplex type 1 mutants and mutants so produced |
-
1996
- 1996-07-26 US US08/687,820 patent/US5972666A/en not_active Expired - Fee Related
-
1997
- 1997-07-25 WO PCT/US1997/014192 patent/WO1998004286A2/en not_active Application Discontinuation
- 1997-07-25 DE DE1997630993 patent/DE69730993T2/de not_active Expired - Fee Related
- 1997-07-25 DK DK97937214T patent/DK0956045T3/da active
- 1997-07-25 CZ CZ99179A patent/CZ17999A3/cs unknown
- 1997-07-25 CA CA 2261071 patent/CA2261071A1/en not_active Abandoned
- 1997-07-25 EP EP97937214A patent/EP0956045B1/en not_active Expired - Lifetime
- 1997-07-25 JP JP50917698A patent/JP2000516597A/ja not_active Ceased
- 1997-07-25 CN CN97198119A patent/CN1230893A/zh active Pending
- 1997-07-25 PT PT97937214T patent/PT956045E/pt unknown
- 1997-07-25 ES ES97937214T patent/ES2231884T3/es not_active Expired - Lifetime
- 1997-07-25 AU AU39779/97A patent/AU3977997A/en not_active Abandoned
- 1997-07-25 AT AT97937214T patent/ATE277634T1/de not_active IP Right Cessation
- 1997-07-25 BR BR9710604A patent/BR9710604A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9710604A (pt) | 1999-08-17 |
EP0956045A2 (en) | 1999-11-17 |
CN1230893A (zh) | 1999-10-06 |
EP0956045B1 (en) | 2004-09-29 |
DE69730993T2 (de) | 2005-10-06 |
CZ17999A3 (cs) | 1999-07-14 |
ATE277634T1 (de) | 2004-10-15 |
US5972666A (en) | 1999-10-26 |
DK0956045T3 (da) | 2005-01-24 |
WO1998004286A2 (en) | 1998-02-05 |
CA2261071A1 (en) | 1998-02-05 |
ES2231884T3 (es) | 2005-05-16 |
JP2000516597A (ja) | 2000-12-12 |
WO1998004286A3 (en) | 1998-05-14 |
AU3977997A (en) | 1998-02-20 |
DE69730993D1 (de) | 2004-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT956045E (pt) | Vacina de herpesvirus deficiente na morfogenese | |
AU6489986A (en) | Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same | |
ES8505719A1 (es) | Procedimiento de preparar mutantes de delecion vivos y metodo de preparar vacunas | |
PT757717E (pt) | Vacinas de papilomavirus | |
ATE288489T1 (de) | Vp-antigene des jc-virus | |
DE3268361D1 (en) | New vaccine and therapy against non-a non-b viral hepatitis, and their preparation process | |
DE69332501D1 (en) | Herpesvirus impfstoffe | |
SE7504221L (sv) | Cellvirusvaccin och forfarande for framstellning av vaccinet. | |
ATE360061T1 (de) | Replikationsmangelhafte mutanten von herpesvirus | |
AR004464A1 (es) | Un metodo para producir una proteina de capside de papilomavirus | |
AU2403188A (en) | Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
CA2116355A1 (en) | Infectious bovine rhinotracheitis virus mutants and vaccines | |
ATE248604T1 (de) | Avirulente herpetische viren verwendbar als tumorzerstörendes agens und impfstoff | |
US4569840A (en) | Thymidine kinase-negative temperature resistant bovine herpesvirus-1 mutant as a vaccine against infectious bovine rhinotracheitis | |
NZ242641A (en) | Herpesvirus particles lacking a capsid and viral dna and viral preparations containing them | |
ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
DK0929315T3 (da) | Krydsbeskyttende equine herpesviruspræparater, deres fremstilling og anvendelse | |
IL81734A0 (en) | Vaccine against herpes simplex | |
CA2247177A1 (en) | Methods for detecting antibodies to hav 3c proteinase | |
GB1498821A (en) | Vaccines | |
Xiao et al. | Experimental studies of a human diploid cell rabies vaccine for human use. | |
ATE46264T1 (de) | Thymidinkinase-negativ-temperaturbestaendiger rinder herpes-virus-1-mutant als vakzin gegen infektioese rinder-rhinotracheitis. |